Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women

被引:383
作者
Bermudez, EA
Rifai, N
Buring, J
Manson, JE
Ridker, PA
机构
[1] Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA
[2] Harvard Univ, Div Cardiovasc Dis, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA
[3] Harvard Univ, Ctr Cardiovasc Dis Prevent, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA
[4] Harvard Univ, Leducq Ctr Cardiovasc Res, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA
[5] Childrens Hosp, Med Ctr, Boston, MA 02115 USA
关键词
interleukin-6; C-reactive protein; risk factors; inflammation; atherosclerosis;
D O I
10.1161/01.ATV.0000029781.31325.66
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Interleukin-6 (IL-6) and C-reactive protein (CRP) are markers of systemic vascular inflammation that herald atherothrombosis and may have important interrelationships with traditional cardiovascular risk factors. Methods and Results-We conducted a cross-sectional analysis among 340 apparently healthy women enrolled in the Women's Health Study. In unadjusted analyses, higher levels of IL-6 and CRP were seen with increasing body mass index (BMI), systolic and diastolic blood pressure, and smoking exposure. IL-6 levels were related to the frequency of alcohol intake (P=0.002) and showed an inverse relationship with exercise frequency and hormone replacement therapy (P<0.0001 for both). CRP levels increased with hormone replacement therapy (P=0.0002). Associations among IL-6, CRP, and lipid levels were minimal. Overall, mean levels of IL-6 and CRP increased with increasing numbers of clinical risk factors (P<0.0001). In multivariate analyses, independent relationships were seen between levels of IL-6 and age, BMI, smoking, systolic blood pressure, alcohol use, presence of diabetes, and frequency of exercise. CRP was associated with age, BMI, systolic blood pressure, high density lipoprotein, smoking, and hormone replacement therapy in adjusted analyses. Conclusions-Plasma levels of IL-6 and CRP are independently related to several clinical cardiovascular risk factors in women.
引用
收藏
页码:1668 / 1673
页数:6
相关论文
共 32 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]  
[Anonymous], 1992, J Myocard. Ischemia
[3]   C-REACTIVE PROTEIN-LEVELS AS A DIRECT INDICATOR OF INTERLEUKIN-6 LEVELS IN HUMANS INVIVO [J].
BATAILLE, R ;
KLEIN, B .
ARTHRITIS AND RHEUMATISM, 1992, 35 (08) :982-983
[4]   Rotation between markers of systemic vascular inflammation and smoking in women [J].
Bermudez, EA ;
Rifai, N ;
Buring, JE ;
Manson, JE ;
Ridker, PM .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (09) :1117-+
[5]   ESSENTIAL ROLE FOR INTERFERON-GAMMA AND INTERLEUKIN-6 IN AUTOIMMUNE INSULIN-DEPENDENT DIABETES IN NOD/WEHI MICE [J].
CAMPBELL, IL ;
KAY, TWH ;
OXBROW, L ;
HARRISON, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :739-742
[6]   INTERLEUKIN-6 IS THE MAJOR REGULATOR OF ACUTE PHASE PROTEIN-SYNTHESIS IN ADULT HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
ANDUS, T ;
GEIGER, T ;
TRULLENQUE, R ;
FABRA, R ;
HEINRICH, PC .
FEBS LETTERS, 1989, 242 (02) :237-239
[7]   Blood pressure and inflammation in apparently healthy men [J].
Chae, CU ;
Lee, RT ;
Rifai, N ;
Ridker, PM .
HYPERTENSION, 2001, 38 (03) :399-403
[8]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[9]   Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly [J].
Harris, TB ;
Ferrucci, L ;
Tracy, RP ;
Corti, MC ;
Wacholder, S ;
Ettinger, WH ;
Heimovitz, H ;
Cohen, HJ ;
Wallace, R .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) :506-512
[10]   PPAR-γ agonists inhibit production of monocyte inflammatory cytokines [J].
Jiang, CY ;
Ting, AT ;
Seed, B .
NATURE, 1998, 391 (6662) :82-86